Log in or Sign up for Free to view tailored content for your specialty!
Therapeutics News
Fewer medications prior to SLT improve chance of success
One-year efficacy of selective laser trabeculoplasty in controlling intraocular pressure was limited in patients with maximal-tolerable medical therapy, according to a study.
Higher glaucoma medication confidence exists when providers educate patients
Researchers found higher patient confidence in adhering to glaucoma medication regimens and confidence to administer eye drops correctly when providers educated patients and assessed their views about glaucoma and its treatment.
Log in or Sign up for Free to view tailored content for your specialty!
Prostaglandins offer greater short-term IOP reduction than other classes
Bimatoprost, latanoprost and travoprost offered the best results at 3 months for primary open-angle glaucoma in a meta-analysis of 114 randomized controlled trials, according to Tianjing Li, MD, PhD, and fellow researchers in Ophthalmology.
Senate committee recommends PATH Act for superbug treatment
A bill aimed at shortening the development time for superbug treatments was recommended today by the U.S. Senate Committee on Health, Education, Labor and Pensions, or HELP.
Ocular surface concerns due to glaucoma agents may be overestimated
Ocular surface changes caused by antiglaucoma medications in stable, medically treated, compliant patients with no dry eye history are mostly subclinical, according to researchers in Investigative Ophthalmology & Visual Science.
AOA announces 2016 hall of fame inductees
The American Optometric Association and Optometry Cares—The AOA Foundation congratulate three AOA member doctors of optometry selected for induction into the National Optometry Hall of Fame.
IOP-reducing effect of hormone therapy likely driven by estrogen
Postmenopausal women with a hysterectomy who received estrogen-alone treatment had a significantly lower IOP than women who received placebo 5 years after initiation of estrogen treatment, according to researchers in the American Journal of Ophthalmology.
Cardiovascular drug may treat pterygium, dry eye symptoms
The MedInsight Research Institute and Center for Drug Repurposing at Ariel University presented positive user-reported outcomes of the off-label drug dipyridamole in treating pterygium and related dry eye symptoms at the Israeli Society for Vision and Eye Research conference on March 10.
BLOG: Our failing dry eye report card
In my practice, we make a lot of effort to follow up with electronic patient questionnaires after office visits or surgery. We want to make sure our treatment or procedure has adequately addressed the problems we were entrusted to solve.
FDA warns public about loose plastic safety seals on eye drop bottles
The FDA is warning the public about eye drop bottles that have loose plastic safety seals or tamper evident rings below the bottle cap, according to a press release from the FDA.